Trials / Conditions / Hereditary Breast and Ovarian Cancer Syndrome

Hereditary Breast and Ovarian Cancer Syndrome

22 registered clinical trials studyying Hereditary Breast and Ovarian Cancer Syndrome — 2 currently recruiting.

Status	Trial	Sponsor	Phase
Recruiting	The FYI on MRI: A Multilevel Decision Support Intervention for Screening Breast MRI NCT06892275	Georgetown University	N/A
Active Not Recruiting	Feasibility Study: IGNITE-TX (Identifying Individuals for Genetic Testing & Treatment) Intervention NCT05677048	M.D. Anderson Cancer Center	N/A
Completed	Pediatric Reporting of Adult-Onset Genomic Results NCT03832985	Geisinger Clinic	EARLY_Phase 1
Completed	Enhance the Use of Genetic Counseling and Testing in Latinas NCT04544501	Georgetown University	N/A
Active Not Recruiting	Direct Information to At-risk Relatives NCT04197856	Umeå University	N/A
Completed	Tissue Expansion in Breast Reconstruction Without Drains NCT03784859	Cedars-Sinai Medical Center	—
Unknown	Risk-Reducing Surgeries for Hereditary Ovarian Cancer NCT03294343	Lei Li	N/A
Unknown	Trial of Inquiry Based Stress Reduction (IBSR) Program for BRCA1/2 Mutation Carriers NCT03162276	Sheba Medical Center	Phase 3
Unknown	Inherited Susceptible Genes Among Epithelial Ovarian Cancer NCT03015376	Peking Union Medical College Hospital	—
Active Not Recruiting	Surgery in Preventing Ovarian Cancer in Patients With Genetic Mutations NCT02760849	M.D. Anderson Cancer Center	N/A
Terminated	Impact of a Psychoeducational Intervention on Expectations and Coping in Young Women Exposed to a High HBOC Ri NCT02705924	Centre Jean Perrin	N/A
Active Not Recruiting	Women at Risk of Breast Cancer and OLFM4 NCT02653105	Institut Cancerologie de l'Ouest	N/A
Recruiting	Development and Validation of an Ovarian Cancer Risk Prediction Model for Family Members of Ovarian Cancer Pro NCT07039552	Peking University Third Hospital	—
Completed	Protexa® Versus TiLoopBra® in Immediate Breast Reconstruction- A Pilot Study NCT02562170	Medical University of Vienna	Phase 4
Completed	Trial of Inquiry Based Stress Reduction (IBSR) Program for BRCA1/2 Mutation Carriers NCT01367639	Sheba Medical Center	Phase 2
Withdrawn	Cost of Cancer Risk Management in Women at Elevated Genetic Risk for Ovarian Cancer Who Participated on GOG-01 NCT01445275	Gynecologic Oncology Group	—
Completed	Search Allelic Imbalance of Expression of BRCA Genes in Hereditary Risk of Breast and/or Ovarian Cancer NCT01333748	Centre Francois Baclesse	Phase 2
Completed	Veliparib in Treating Patients With Malignant Solid Tumors That Do Not Respond to Previous Therapy NCT00892736	National Cancer Institute (NCI)	Phase 1
Completed	Telemedicine vs. Face-to-Face Cancer Genetic Counseling NCT00609505	Duke University	N/A
Completed	Statewide Communication to Reach Diverse Low Income Women NCT02956681	University of California, San Francisco	N/A
Completed	Veliparib, Carboplatin, and Paclitaxel in Treating Patients With Advanced Solid Cancer NCT00535119	National Cancer Institute (NCI)	Phase 1
Completed	Zoledronate or Observation in Maintaining Bone Mineral Density in Patients Who Are Undergoing Surgery to Remov NCT00305695	Gynecologic Oncology Group	Phase 2